Los Angeles Capital Management’s Surmodics SRDX Stock Holding History
Bought
Maintained
Sold
Other funds holding SRDX
SCM
TI
GF
Los Angeles Capital Management's SRDX Position: Q4 2024 in Review
Los Angeles Capital Management sold out of Surmodics (SRDX) in Q4 2024, closing a stake of 27,950 shares — an estimated $1.08M sold.
Los Angeles Capital Management first reported a position in SRDX in Q3 2018 and held it in 19 quarters. The position peaked at $1.53M in Q2 2024. 139 funds tracked by Wall St. Rank hold SRDX as of Q4 2024.
- Los Angeles Capital Management reported no remaining Surmodics position as of Q4 2024 after selling out during the quarter.
- Los Angeles Capital Management sold 27,950 Surmodics shares in Q4 2024, an estimated $1.08M.
- Los Angeles Capital Management first reported a position in Surmodics in Q3 2018 and held it in 19 quarters.
- Los Angeles Capital Management's Surmodics position peaked at $1.53M in Q2 2024.
- 139 funds tracked by Wall St. Rank held Surmodics as of Q4 2024.
Based on Los Angeles Capital Management's 13F filing for Q4 2024, filed 4 Feb 2025.